Moderna says COVID-19 Vaccine Provides One Year's Immunity
Click the image below to enlarge the infographic.
- Drug maker, Moderna, announced Monday that its COVID-19 vaccine confers immunity for at least one year after vaccination
- Moderna CEO Stéphane Bance said this in a JP Morgan Healthcare Conference Monday, adding that the company is on track to deliver more than 600 million doses of the vaccine in 2021
- However, experts have raised concerns about the efficacy of the vaccine to protect against the new coronavrius variants spreading much faster than previous strains
- Bance said that the vaccines could easily be tweaked to adapt to the new variants, some of which have distorted spike protein structure
- The company has predicted $11.7 billion in vaccine-related sales this year based on advance purchase agreements signed with governments